Physician profile
Abir Rahman
NPI 1043620040
$2,336.49
in general payments reported to CMS, 2019-2025
4 companies · $22.77 in 2025
The $22.77 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.16 · 2022: $69.57 · 2023: $2,012 · 2024: $198 · 2025: $22.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,750 · Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,750.00 |
| Food and Beverage | $482.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $1,881.57 | 2023 | Relyvrio |
| Xeris Pharmaceuticals, INC. | $272.02 | 2022-2024 | Keveyis |
| Tanabe Pharma America, INC. | $148.74 | 2022-2025 | Radicava |
| Fujifilm Sonosite, INC. | $34.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abir Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.